Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
– SKYTROFA, the first FDA approved treatment utilizing TransCon™ technology, is a long-acting prodrug of…
Kinetic Deploys AI-Powered Fiber Design Platform to Connect Fiber Customers Faster
SAP Helps CHKP Group Connect Online and Offline Retail to Deliver Personalised Experiences at AV Life and FOTOMAX